Get the Stockscreener App
12.66
4.11%
0.50
Dariohealth Corp stock is traded at $12.66, with a volume of 25,305.
It is up +4.11% in the last 24 hours and down -2.69% over the past month.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
See More
Previous Close:
$12.16
Open:
$12.16
24h Volume:
25,305
Relative Volume:
0.38
Market Cap:
$85.69M
Revenue:
$20.35M
Net Income/Loss:
$-59.43M
P/E Ratio:
-12.29
EPS:
-1.03
Net Cash Flow:
$-30.96M
1W Performance:
+6.84%
1M Performance:
-2.69%
6M Performance:
-11.51%
1Y Performance:
-10.86%
1-Day Range:
$12.12
$13.30
1-Week Range:
$11.77
$13.30
52-Week Range:
$5.935
$31.00
Dariohealth Corp Stock (DRIO) Company Profile
Name
Dariohealth Corp
Sector
Industry
Phone
972-4-770-6377
Address
322 W 57TH ST. #33B, NEW YORK
Compare DRIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DRIO
Dariohealth Corp
|
12.66 | 82.30M | 20.35M | -59.43M | -30.96M | -1.03 |
|
VEEV
Veeva Systems Inc
|
229.16 | 38.14B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
75.07 | 13.50B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
45.04 | 8.50B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
95.73 | 7.97B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
35.20 | 6.39B | 11.99B | 24.18M | 234.31M | 0.2956 |
Dariohealth Corp Stock (DRIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-29-25 | Downgrade | TD Cowen | Buy → Hold |
| May-13-22 | Upgrade | Alliance Global Partners | Neutral → Buy |
| Apr-22-21 | Initiated | Cowen | Outperform |
| Mar-23-21 | Initiated | Stifel | Buy |
| Feb-25-21 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-01-21 | Downgrade | Alliance Global Partners | Buy → Neutral |
| Aug-17-20 | Initiated | Aegis Capital | Buy |
| Aug-29-17 | Initiated | Aegis Capital | Buy |
| May-09-16 | Initiated | Rodman & Renshaw | Buy |
View All
Dariohealth Corp Stock (DRIO) Latest News
Dario Launches DarioIQ™ AI Integration in Dario Health App with Direct-to-Consumer First Version for Hypertension Members - PR Newswire
DarioHealth (NASDAQ: DRIO) prices 2,713,180-share private placement for $17.5M - Stock Titan
DarioHealth Corp. (NASDAQ:DRIO) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
DarioHealth is Gaining Strong Momentum as GLP-1 Costs Reshape Employer Health Strategy (NASDAQ: DRIO) - TradingView
How interest rate cuts could boost DarioHealth Corp. stockWeekly Investment Recap & Fast Entry Momentum Trade Alerts - Newser
DarioHealth (NASDAQ: DRIO) JMIR Cardio study links digital nudges to better BP - Stock Titan
DarioHealth Far Exceeds 2025 New Client Target with 79 New Accounts Signed Year-to-Date - Lelezard
DarioHealth exceeds 2025 client target with 79 new accounts By Investing.com - Investing.com Australia
DarioHealth (DRIO) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
DarioHealth exceeds 2025 client target with 79 new accounts - Investing.com
DarioHealth (NASDAQ:DRIO) Stock Price Passes Below Two Hundred Day Moving AverageWhat's Next? - MarketBeat
Market Moves: Why DarioHealth Corp. stock is popular among millennialsProfit Target & Real-Time Buy Signal Notifications - moha.gov.vn
DarioHealth Announces 20-to-1 Reverse Stock Split (PR Newswire) - Aktiellt
DarioHealth Reports Second Quarter 2025 Financial and Operating Results (PR Newswire) - Aktiellt
DarioHealth stock rises after peer-reviewed study shows cost savings By Investing.com - Investing.com Nigeria
DarioHealth stock rises after peer-reviewed study shows cost savings - Investing.com India
Dario’s digital diabetes platform cuts healthcare costs by 23% - Investing.com UK
DarioHealth Announces Publication of Sanofi Study in JMIR Demonstrating an Estimated $5,077 Medical Cost Savings Per Dario Digital Health Platform User Per Year - Nasdaq
Can DarioHealth Corp. stock sustain free cash flow growth2025 Dividend Review & Risk Controlled Daily Trade Plans - newser.com
Is DarioHealth Corp. stock attractive for income investors - newser.com
Will DarioHealth Corp. stock beat EPS estimatesQuarterly Portfolio Report & High Accuracy Trade Signal Alerts - newser.com
What makes DarioHealth Corp. stock attractive to growth fundsWeekly Trend Report & Fast Gain Stock Tips - newser.com
Will DarioHealth Corp. stock recover after recent dropJuly 2025 Snapshot & Free Low Drawdown Momentum Trade Ideas - newser.com
How risky is DarioHealth Corp. stock nowJuly 2025 Catalysts & Advanced Technical Signal Analysis - newser.com
How to use Fibonacci retracement on DarioHealth Corp.Market Risk Report & Reliable Intraday Trade Alerts - newser.com
Using flow based indicators on DarioHealth Corp.Weekly Investment Recap & Fast Moving Market Watchlists - newser.com
Will DarioHealth Corp. stock see insider buyingPortfolio Profit Report & Technical Entry and Exit Alerts - newser.com
DarioHealth (DRIO) Price Target Decreased by 10.11% to 20.40 - MSN
Published on: 2025-11-18 20:28:27 - newser.com
Relative strength of DarioHealth Corp. in sector analysisTrade Analysis Summary & Short-Term High Return Strategies - newser.com
How DarioHealth Quietly Became One of the Most Intriguing Setups in Digital Health Heading Into 2026 - MarketScreener
Will DarioHealth Corp. stock split attract more investors2025 Top Decliners & Free Risk Controlled Daily Trade Plans - newser.com
Dariohealth Corp Stock (DRIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.74%
4.47%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):